Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Immunology

Disease Area Infectious diseases

Rage Against the Dying of the Light

Sitting Down With… Jose Pulido, Larry A. Donoso Endowed Chair, Wills Eye

Disease Area Infectious diseases

The COVID-19 Pandemic: A Summary

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

Research Field Microbiology

Breaking Down Walls

| Danny Ward

To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research.

Disease Area Cancer

Proving the worth of ICIs

| Jonathan James

New evidence points to the safety – and benefits – of immune checkpoint therapy in HIV-positive cancer patients

Disease Area Infectious diseases

Andes Antibody Advancement

| Jonathan James

A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)

Disease Area Immunology

Just One Shot

| Stephanie Sutton

A vaccine using mRNA demonstrates potential for broad influenza protection.

Research Field Immunology

Not Immune to Damage

| Ruth Steer

Could activated T cells play a major role in driving neurodegeneration in glaucoma?

Research Field Drug discovery

Antibody About Turn

| Sam Cobb

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

Research Field Drug discovery

Believe in RNAi

| Geert Cauwenbergh

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender

Research Field Drug delivery

Recognizing Friend from Foe

| Werner Cautreels

Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register